Top Breast Panel Multi-Tumor control slides

Multipanel immunofluorescence evaluation of tumor infiltrating lymphocytes in triple adverse breast most cancers: Evolution of tumor immune profiles and affected person prognosis.

 

  • The evolutionary adjustments in immune profiles of triple adverse breast most cancers (TNBC) aren’t properly understood, though it’s identified that immune checkpoint inhibitors have diminished exercise in closely pre-treated TNBC sufferers. This examine was designed to characterize immune profile adjustments of longitudinal tumor specimens by learning immune subsets of tumor infiltrating lymphocytes (TILs) in paired main and metastatic TNBC in a cohort of “poor end result” (relapsed inside 5 years) sufferers.

 

  • Immune profiles of TNBCs in a cohort of “good end result” (no relapse inside 5 years) sufferers have been additionally analyzed. Immune subsets have been characterised for CD4, CD8, FOXP3, CD20, CD33, and PD1 utilizing immuno-fluorescence staining in stroma, tumor, and mixed stroma and tumor tissue. TIL subsets in “good end result” versus “poor end result” sufferers have been additionally analyzed. In contrast with main, metastatic TNBCs had considerably decrease TILs by hematoxylin and eosin (H&E) staining.

HAV HAV P2C recombinant antigen

  • Stromal TILs (sTILs), however not tumoral TILs (tTILs) had considerably lowered cytotoxic CD8+ T cells (CTLs), PD1+ CTLs, and whole PD1+ TILs in metastatic in contrast with matched main TNBCs. Greater PD1+ CTLs, PD1+CD4+ helper T cells (PD1+TCONV) and all PD1+ T cells in sTILs, tTILs and whole stromal and tumor TILS (s+tTIL) have been all related to higher prognosis.

 

  • In abstract, TIL subsets lower considerably in metastatic TNBCs in contrast with matched main. Hellogher PD1+ TILs are related to higher prognosis in early stage TNBCs. This discovering helps the appliance of immune checkpoint inhibitors early within the remedy of TNBCs

Tetranectin (CLEC3B) Antibody

Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgG antiserum negative control

970-360-01N 1 ml
EUR 196.8

Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgG antiserum positive control

970-360-02P 1 ml
EUR 270

Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgM antiserum negative control

970-370-01N 1 ml
EUR 196.8

Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgM antiserum positive control

970-370-02P 1 ml
EUR 270

Labcold Gel Pack for Vaccine Transport Bag - EACH

REF4120 EACH
EUR 5.92

BCG vaccine

VAC-0001 0.5ml
EUR 2398.4
Description: Protein

Protein Kinase C, Panel, Western Blot Control (PKC)

MBS652621-1Panel 1Panel
EUR 850

Protein Kinase C, Panel, Western Blot Control (PKC)

MBS652621-5x1Panel 5x1Panel
EUR 3600

rsPSMA Vaccine

NG2-352 1 vial
EUR 798.4
Description: Protein

Anthrax vaccine

VAC-0342 0.5ml
EUR 1598.4
Description: Protein

Typhoid Vaccine

VAC-0356 0.5ml
EUR 1598.4
Description: Protein

Bordetella bronchiseptica proteins (inactivated vaccine for dog) for ELISA

BBV15-N-100 100 ug
EUR 343.2

Rotavirus vaccine

VAC-0352 0.5ml
EUR 1598.4
Description: Protein

Core Panel Multi-Tumor control slides, set of 5

TS900 Set of 5
EUR 165

Core Panel Multi-Tumor control slides, set of 25

TS900-25 Set of 25
EUR 445

Breast Panel Multi-Tumor control slides, set of 5

TS901 Set of 5
EUR 165

Breast Panel Multi-Tumor control slides, set of 25

TS901-25 Set of 25
EUR 445

RUTI® Vaccine

VAC-0353 0.5ml
EUR 1598.4
Description: Protein

Labcold Rigid Cool Block for Vaccine Transport Bag - EACH

REF4122 EACH
EUR 22.37

Control Animal Genomic DNA Panel, Set of any 5 species

G-005 5X0.025mg
EUR 720

Control Animal Genomic DNA Panel, Set of any 10 species

G-010 10x0.025mg
EUR 1193

Vaccine adjuvant-1

HY-160198 Get quote Ask for price
Description: Vaccine adjuvant-1 is an vaccine adjuvant is a vaccine adjuvant containing an oil phase, emulsifying agent and water[1].

Hepatitis A Vaccine

SARS-401 1 vial
EUR 798.4
Description: Protein

Yellow Fever Vaccine

VAC-0339 0.5ml
EUR 1598.4
Description: Protein

Recombinant flagellin FlicC vaccine adjuvant (TLR5 agonist); vaccine adjuvant

AV-7010-50 50 ug
EUR 1074

Rubella Virus Vaccine

VAC-0323 0.5ml
EUR 1598.4
Description: Protein

SARS-CoV-2 Spike RBD ELISA Kit (For Vaccine Development)

RAS-A050 96tests
EUR 643.1
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike Protein RBD is urgently needed to accelerate the development of COVID-19 vaccines.

Rabies virus Glycoprotein G ELISA Kit (For Vaccine Development)

RAS-A167 96tests
EUR 643.1
Description: Rabies virus (RABV), scientific name Rabies lyssavirus, is a deadly neurotropic virus that causes rabies in humans and animals. Rabies virus has an extremely wide host range and its transmission most often occur through the saliva of animals. Without intervention prior to disease progression, rabies has the highest case fatality of any infectious disease. RABV contains a single-stranded negative-sense R genome that encodes five structural proteins: nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), and R-dependent R polymerase (L). Among these viral proteins, the RABV glycoprotein (RABV-G) is a pivotal player mediating virus entry and the major target of neutralizing antibodies, thus a key factor for vaccine and drug design.A rapid and effective assay kit detecting the levels ofRABV-G is urgently needed to accelerate the development of RABV vaccines.

Varicella Vaccine, Live

VAC-0378 0.5ml
EUR 1598.4

Smallpox (Vaccinia) Vaccine, Live

VLP-353 1 vial
EUR 798.4
Description: Protein

Recombinant BCG Vaccine

PFC-338 1 vial
EUR 798.4
Description: Protein

Mycobacterium w. Vaccine

COV2-370 1 vial
EUR 798.4
Description: Protein

Saponin Vaccine Adjuvant

VAdv-Ly0009 1 g
EUR 1314
Description: Saponin Vaccine Adjuvant, plant-based vaccine adjuvant.

SARS-CoV-2 Spike Protein ELISA Kit (For Vaccine Development)

RAS-A039 96tests
EUR 643.1
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

Rabbit Anti-West Nile Virus vaccine (WNV, Recombitek/DNA vaccine) antiserum

WNV13-S 100 ul
EUR 548.4

Customized Organic Acids Panel-2 in Urine Lyophilized Control Level 1

ZV-3066-02K1-20 1 x 3mL Ask for price

Vaccine adjuvant-1 (GMP)

HY-160198G Get quote Ask for price
Description: Vaccine adjuvant-1 GMP is Vaccine adjuvant-1 produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Vaccine adjuvant-1 is an vaccine adjuvant is a vaccine adjuvant containing an oil phase, emulsifying agent and water[1].

Labcold Trolley for Use with 20L/30L Vaccine Transport Bags - EACH

REF4118 EACH
EUR 286.42

Moderna COVID-19 Vaccine

H7N7-319 1 vial
EUR 798.4
Description: Protein

Peanut Oil vaccine adjuvant

AV-5010-50 50 ml
EUR 270

MUC1 Dendritic Cell Vaccine

VAC-0369 0.5ml
EUR 1598.4
Description: Protein

SARS-CoV-2 Spike RBD (XBB.1.5) ELISA Kit (For Vaccine Development)

RAS-A146 96tests
EUR 861.1
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike RBD is urgently needed to accelerate the development of COVID-19 vaccines.

Mineral Oil vaccine adjuvant

AV-5020-50 50 ml
EUR 270

SARS-CoV-2 Spike Trimer (XBB.1.5) ELISA Kit (For Vaccine Development)

RAS-A145 96tests
EUR 861.1
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike Trimer is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike Trimer (XBB.1) ELISA Kit (For Vaccine Development)

RAS-A149 96tests
EUR 861.1
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike Trimer is urgently needed to accelerate the development of COVID-19 vaccines.

Dengue tetravalent vaccine, live

VZV-421 1 vial
EUR 798.4
Description: Protein

HS15 Kolliphore vaccine adjuvant

AV-6010-100 100 g
EUR 343.2

Recombinant Hepatitis B Vaccine

NG2-351 1 vial
EUR 798.4
Description: Protein

Pam2CSK4 vaccine adjuvant; Biotin conjugate

AV-9020-B 1 mg
EUR 489.6

Pam2CSK4 vaccine adjuvant; Biotin conjugate

AV-9020-B-100 100 ug
EUR 196.8

Typhoid Vi polysaccharide vaccine

VAC-0357 0.5ml
EUR 1598.4
Description: Protein

Calcium phosphate vaccine adjuvant

AV-1020-100 100 ml
EUR 262.8

Mannide monooleate vaccine adjuvant

AV-5030-5 5 g
EUR 196.8

Pam2CSK4 vaccine adjuvant, unlabeled

AV-9020-1 1 mg
EUR 489.6

Pam3CSK4 vaccine adjuvant, unlabeled

AV-9025-1 1 mg
EUR 343.2

Recombinant Varicella Zoster Vaccine

VAC-0270 0.5ml
EUR 1598.4
Description: Protein

BNT162c2 SARS-CoV-2 Vaccine

INB-326 1 vial
EUR 798.4
Description: Protein

Adenovirus type 7 vaccine live

MPC-341 1 vial
EUR 798.4
Description: Protein

 

 

Detection of Germline Mutations in Breast Most cancers Sufferers with Medical Options of Hereditary Most cancers Syndrome Utilizing a Multi-Gene Panel Take a look at.

 

Hereditary most cancers syndrome signifies that inherited genetic mutations can improve an individual’s danger of creating most cancers.

Tetranectin Polyclonal Antibody

 

We assessed the frequency of germline mutations utilizing an NGS-based multiple-gene panel containing 64-cancer predisposing genes in Korean breast most cancers sufferers with medical options of hereditary breast and ovarian most cancers syndrome (HBOC).A complete of 64 genes related to hereditary most cancers syndrome have been chosen for improvement of an NGS-based multi-gene panel.

Human Tetranectin (CLEC3B) ELISA Package

Focused sequencing utilizing the multi-gene panel was carried out to establish germline mutations in 496 breast most cancers sufferers with medical options of HBOC who underwent breast most cancers surgical procedure between January 2002 and December 2017.Of 496 sufferers, 95 sufferers (19.2%) have been discovered to have 48 deleterious germline mutations in 16 most cancers susceptibility genes.

Human Tetranectin ELISA Kit

MBS2882980-10x96StripWells 10x96-Strip-Wells
EUR 4080

Human Tetranectin ELISA Kit

MBS2882980-48StripWells 48-Strip-Wells
EUR 390

Human Tetranectin ELISA Kit

MBS2882980-5x96StripWells 5x96-Strip-Wells
EUR 2220

Human Tetranectin ELISA Kit

MBS2882980-96StripWells 96-Strip-Wells
EUR 520

Human Tetranectin ELISA Kit

MBS762655-10x96StripWells 10x96-Strip-Wells
EUR 3900

Human Tetranectin ELISA Kit

MBS762655-48StripWells 48-Strip-Wells
EUR 340

Human Tetranectin ELISA Kit

MBS762655-5x96StripWells 5x96-Strip-Wells
EUR 2045

Human Tetranectin ELISA Kit

MBS762655-96StripWells 96-Strip-Wells
EUR 455

Human Tetranectin ELISA Kit

MBS824758-5x96Tests 5x96Tests
EUR 2880

Human Tetranectin ELISA Kit

MBS824758-96Tests 96Tests
EUR 645

Human Tetranectin ELISA Kit

MBS9427171-5x96Tests 5x96Tests
EUR 2820

Human Tetranectin ELISA Kit

MBS9427171-96Tests 96Tests
EUR 615

Human Tetranectin Antibody Pair Set

ABPR-ZB221 5 plates, 15 plates Ask for price
Description: Quantitative determination of Human Tetranectin

ELISA Kit for Human Tetranectin

E1411h 96T
EUR 387.4

Tetranectin

AP78991 1mg
EUR 2640

Tetranectin

AP88122 1mg
EUR 2640

Tetranectin

AP88508 1mg
EUR 2640

Tetranectin

E8ET7108-45 100ul
EUR 275
Description: Available in various conjugation types.

Tetranectin

MBS8565864-01mL 0.1mL
EUR 345

Tetranectin

MBS8565864-01mLAF405L 0.1mL(AF405L)
EUR 565

Tetranectin

MBS8565864-01mLAF405S 0.1mL(AF405S)
EUR 565

Tetranectin

MBS8565864-01mLAF610 0.1mL(AF610)
EUR 565

Tetranectin

MBS8565864-01mLAF635 0.1mL(AF635)
EUR 565

Recombinant Human Tetranectin (CLEC3B)

CSB-EP005531HU 11018 mg Ask for price

Recombinant Human Tetranectin (CLEC3B)

CSB-EP005531HU-100ug 100ug Ask for price
Description: 22-202aa

Recombinant Human Tetranectin (CLEC3B)

CSB-EP005531HU-1mg 1mg Ask for price
Description: 22-202aa

Recombinant Human Tetranectin (CLEC3B)

CSB-EP005531HU-20ug 20ug Ask for price
Description: 22-202aa

Recombinant Human Tetranectin (CLEC3B)

MBS965439-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1100

Recombinant Human Tetranectin (CLEC3B)

MBS965439-002mgEColi 0.02mg(E-Coli)
EUR 700

Recombinant Human Tetranectin (CLEC3B)

MBS965439-002mgYeast 0.02mg(Yeast)
EUR 855

Recombinant Human Tetranectin (CLEC3B)

MBS965439-01mgEColi 0.1mg(E-Coli)
EUR 810

Recombinant Human Tetranectin (CLEC3B)

MBS965439-01mgYeast 0.1mg(Yeast)
EUR 1000

Mouse anti Human CLEC3B/Tetranectin Monoclonal Antibody

MBS2543718-006mL 0.06mL
EUR 250

Mouse anti Human CLEC3B/Tetranectin Monoclonal Antibody

MBS2543718-012mL 0.12mL
EUR 370

Mouse anti Human CLEC3B/Tetranectin Monoclonal Antibody

MBS2543718-02mL 0.2mL
EUR 550

Human Tetranectin(CLEC3B) ELISA kit

CSB-EL005531HU-24T 1 plate of 24 wells
EUR 198
Description: Quantitativesandwich ELISA kit for measuring Human Tetranectin (CLEC3B) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human Tetranectin(CLEC3B) ELISA kit

CSB-EL005531HU-48T 48T
EUR 338.81
Description: Homo sapiens (Human)

Human Tetranectin(CLEC3B) ELISA kit

1-CSB-EL005531HU
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 plate of 96 wells
  • 5 plates of 96 wells each
  • 10 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Human Tetranectin(CLEC3B) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Human Tetranectin(CLEC3B) ELISA kit

CSB-EL005531HU-96T 96T
EUR 521.25
Description: Homo sapiens (Human)

Human Tetranectin(CLEC3B) ELISA kit

E01A8123 96T
EUR 700
Description: ELISA

Human Tetranectin (CLEC3B) ELISA Kit

abx252170-96tests 96 tests
EUR 801.6

Human Tetranectin(CLEC3B) ELISA kit

E01T0030-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Tetranectin(CLEC3B) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Tetranectin(CLEC3B) ELISA kit

E01T0030-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human Tetranectin(CLEC3B) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Tetranectin(CLEC3B) ELISA kit

E01T0030-48wellsplate 48 wells plate
EUR 280

Human Tetranectin(CLEC3B) ELISA kit

E01T0030-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human Tetranectin(CLEC3B) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Tetranectin(CLEC3B) ELISA kit

E01T0030-96wellsplate 96 wells plate
EUR 405

Human Tetranectin (CLEC3B) ELISA Kit

IHUCLEC3BKT each
EUR 702
Description: Human Tetranectin (CLEC3B) ELISA Kit

Human Tetranectin,CLEC3B ELISA KIT

JOT-EK6262Hu 96 wells Ask for price
Description: Human

Human Tetranectin, CLEC3B ELISA KIT

ELI-04595h 96 Tests
EUR 988.8

Human Tetranectin/ CLEC3B ELISA Kit

ELA-E14924h 96 Tests
EUR 988.8

Human Tetranectin (CLEC3B) ELISA Kit

MBS139558-1Kit 1Kit
EUR 755

Human Tetranectin (CLEC3B) ELISA Kit

MBS139558-5x1Kit 5x1Kit
EUR 3455

Human Tetranectin(CLEC3B) Elisa Kit

EK711923 96 Wells
EUR 0.22

Human Tetranectin(CLEC3B) ELISA kit

EKC35749-48T 48T
EUR 535.99

The deleterious mutations have been present in 39 of 250 sufferers (15.6%) who had breast most cancers and one other main most cancers, 38 of 169 sufferers (22.5%) who had a household historical past of breast most cancers (≥ 2 family members), 16 of 57 sufferers (28.1%) who had bilateral breast most cancers, and 29 of 84 sufferers (34.5%) who have been recognized with breast most cancers at youthful than 40 years of age.

Human CellExp? CLEC3B / Tetranectin, Human recombinant

Of the 95 sufferers with deleterious mutations, 60 sufferers (63.2%) had BRCA1/2 mutations and 38 sufferers (40.0%) had non-BRCA1/2 mutations. We detected 2 novel deleterious mutations in BRCA2 and MLH1.NGS-based multiple-gene panel testing improved the detection charges of deleterious mutations and supplied a cheap most cancers danger evaluation.